Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03583697
Recruitment Status : Enrolling by invitation
First Posted : July 11, 2018
Last Update Posted : May 24, 2019
Sponsor:
Information provided by (Responsible Party):
BioMarin Pharmaceutical

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : May 2021
Estimated Study Completion Date : May 2021